Skip to main content
logo
Prelude Therapeutics Incorporated (PRLD)
NASDAQ: PRLD · Real-Time Price · USD
3.680
+0.220 (6.36%)
At close: Apr 6, 2026, 4:00 PM EDT
3.750
+0.070 (1.90%)
After-hours: Apr 6, 2026, 7:12 PM EDT

Prelude Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Cap
30418370234289593
Market Cap Growth
442.20%160.66%-70.13%-18.95%-51.18%-81.05%
Enterprise Value
218.394.4-48.2520.2987.58301.42
Last Close Price
3.682.901.274.276.0412.45
PE Ratio
--2.25-0.76-2.11-2.48-5.12
PS Ratio
25.0215.0410.01---
PB Ratio
4.422.660.530.991.482.07
P/TBV Ratio
4.133.250.731.091.462.01
P/FCF Ratio
--3.24-0.68-2.12-3.34-6.90
P/OCF Ratio
--3.24-0.68-2.19-3.46-7.09
EV/Sales Ratio
17.987.78-6.89---
EV/EBITDA Ratio
--0.920.35-0.15-0.72-2.67
EV/EBIT Ratio
--0.900.35-0.15-0.71-2.65
EV/FCF Ratio
--1.670.47-0.18-1.01-3.51
Debt / Equity Ratio
0.220.220.120.0800
Debt / EBITDA Ratio
-0.17-0.17-0.13-0.15-0.01-0.01
Debt / FCF Ratio
-0.32-0.32-0.17-0.18-0.02-0.02
Net Debt / Equity Ratio
-1.25-1.25-0.88-0.90-1.02-1.01
Net Debt / EBITDA Ratio
0.830.830.841.621.642.57
Net Debt / FCF Ratio
1.521.521.121.922.303.37
Asset Turnover
0.080.080.03000
Quick Ratio
1.951.955.2110.679.3015.17
Current Ratio
1.991.995.3010.799.4215.37
Return on Equity (ROE)
-99.45%-99.45%-69.01%-56.33%-47.97%-44.85%
Return on Assets (ROA)
-66.01%-66.01%-61.66%-53.11%-47.01%-43.03%
Return on Invested Capital (ROIC)
-515.80%-515.80%-644.70%-1136.21%5263.74%2347.47%
Return on Capital Employed (ROCE)
-87.80%-87.80%-68.87%-58.19%-50.98%-45.67%
Earnings Yield
-32.76%-44.48%-132.28%-47.31%-40.40%-19.52%
FCF Yield
-18.56%-30.88%-147.99%-47.16%-29.98%-14.49%
Buyback Yield / Dilution
-1.52%-1.52%-25.60%-27.41%-2.87%-269.03%
Total Shareholder Return
-1.52%-1.52%-25.60%-27.41%-2.87%-269.03%
Updated Mar 10, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q